journal article·2023-02-14Open access

Supercritical CO2 Synthesis of Porous Metalloporphyrin Frameworks: Application in Photodynamic Therapy

Márta Kubovics, Oriol Careta, Oriol Vallcorba, Guillermo Romo-Islas, Laura Rodríguez, Jose A. Ayllón, Concepción Domingo, Carme Nogués, Ana M. López-Periago

Chemistry of Materials· Volume 35· Issue 3

Abstract

High Resolution Image Download MS PowerPoint Slide A series of porous metalloporphyrin frameworks prepared from the 5,10,15,20-tetra(4-pyridyl)porphyrin (H 2 TPyP) linker and four metal complexes, M(hfac) 2 M = Cu(II), Zn(II), Co(II), and Ni(II) (hfac: 1,1,1,5,5,5-hexafluoroacetylacetonate), were obtained using supercritical CO 2 (scCO 2 ) as a solvent. All the materials, named generically as [M-TPyP] n, formed porous metal–organic frameworks (MOFs), with surface areas of ∼450 m 2 g –1 . All MOFs were formed through the coordination of the metal to the exocyclic pyridine moieties in the porphyrin linker. For Cu(II), Zn(II), and Co(II), incomplete metal coordination of the inner pyrrole ring throughout the structure was observed, giving place to MOFs with substitutional defects and leading to a certain level of disorder and limited crystallinity. These samples, prepared using scCO 2, were precipitated as nano- to micrometric powders. Separately, a layering technique from a mixture of organic solvents was used to crystallize high-quality crystals of the Co(II) based MOF, obtained with the formula [{Co(hfac) 2 } 2 H 2 TPyP] n . The crystal structure of this MOF was elucidated by single-crystal synchrotron X-ray diffraction. The Zn(II)-based MOF was selected as a potential photodynamic therapy drug in the SKBR-3 tumoral cell line showing outstanding performance. This MOF resulted to be nontoxic, but after 15 min of irradiation at 630 nm, using either 1 or 5 μM concentration of the product, almost 70% of tumor cells died after 72 h.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Metal-Organic Frameworks: Synthesis and Applications · Nanoplatforms for cancer theranostics · Porphyrin and Phthalocyanine Chemistry

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Materials Science of Barcelona (ICMAB-CSIC), Campus UAB s/n, 08193Bellaterra, Spain

Department de Biologia Cel·lular, Fisiologia i Immunologia. Universtitat Autònoma de Barcelona (UAB), Campus UAB s/n, 08193Bellaterra, Spain

ALBA Synchrotron Light Source, 08290Cerdanyola del Vallés, Spain

Department of Inorganic and Organic Chemistry, Barcelona University, Martí i Franquès 1-11, 08028Barcelona, Spain

Institute of Nanoscience and Nanotechnology (IN2UB), Barcelona University, Campus UB s/n, 08028Barcelona, Spain

Department de Química, Universtitat Autònoma de Barcelona (UAB), Campus UAB s/n, 08193Bellaterra, Spain

Funding

Ministerio de Ciencia e Innovación · H2020 Marie Sklodowska-Curie Actions · Generalitat de Catalunya

References (49)

Show source-provided references
1. 10.1002/anie.20150186210.1002/anie.201501862 ↗
2. 10.1021/jacs.8b0952110.1021/jacs.8b09521 ↗
3. 10.1021/ja402727d10.1021/ja402727d ↗
4. 10.1016/s0010-8545(99)00106-x10.1016/s0010-8545(99)00106-x ↗
5. 10.1039/c3cc44794d10.1039/c3cc44794d ↗
6. 10.1016/j.ccr.2004.02.00410.1016/j.ccr.2004.02.004 ↗
7. 10.18632/oncotarget.2018910.18632/oncotarget.20189 ↗
8. 10.1039/b915149b10.1039/b915149b ↗
9. 10.1016/j.breast.2016.09.01610.1016/j.breast.2016.09.016 ↗
10. 10.1016/j.ccr.2020.21341010.1016/j.ccr.2020.213410 ↗
11. 10.1042/bj2015094210.1042/bj20150942 ↗
12. 10.1016/j.msec.2021.11251410.1016/j.msec.2021.112514 ↗
13. 10.1021/ja508679h10.1021/ja508679h ↗
14. 10.1021/jacs.6b0000710.1021/jacs.6b00007 ↗
15. 10.1021/ic401853610.1021/ic4018536 ↗
16. 10.1002/anie.20180976210.1002/anie.201809762 ↗
17. 10.1039/c7cc03499g10.1039/c7cc03499g ↗
18. 10.1016/j.jssc.2017.01.01210.1016/j.jssc.2017.01.012 ↗
19. Cai, P.; Huang, Y.; Smith, M.; Zhou, H. Structural Design of Porphyrin-Based MOFs. Chapter 1 in: Porphyrin-Based Supramolecular Architectures: From Hierarchy to Functions; Royal Society of Chemistry, 2021; pp 1–58.10.1039/9781839164934-00001 ↗
20. 10.1007/s10870-008-9474-z10.1007/s10870-008-9474-z ↗
21. 10.1039/b417709f10.1039/b417709f ↗
22. 10.1021/ic060358h10.1021/ic060358h ↗
23. 10.1039/b920109b10.1039/b920109b ↗
24. 10.1016/j.supflu.2021.10537910.1016/j.supflu.2021.105379 ↗
25. 10.1039/C5DT00521C10.1039/C5DT00521C ↗
26. 10.1039/c7ce00909g10.1039/c7ce00909g ↗
27. 10.1016/j.ica.2020.12013210.1016/j.ica.2020.120132 ↗
28. 10.1016/j.micromeso.2016.07.01410.1016/j.micromeso.2016.07.014 ↗
29. 10.1021/acssuschemeng.8b0273810.1021/acssuschemeng.8b02738 ↗
30. 10.1039/D0RA09132D10.1039/D0RA09132D ↗
31. 10.1021/acsanm.1c0330110.1021/acsanm.1c03301 ↗
32. Subra-Paternault P. · 2015
33. 10.1107/s090744490904733710.1107/s0907444909047337 ↗
34. 10.1107/s205322961402421810.1107/s2053229614024218 ↗
35. 10.1107/s002188980804272610.1107/s0021889808042726 ↗
36. 10.1002/open.20140209210.1002/open.201402092 ↗
37. Gupta R. B. · 200610.1201/9781420005998 ↗
38. 10.1016/j.jcou.2017.01.01910.1016/j.jcou.2017.01.019 ↗
39. 10.1039/c5ra02440d10.1039/c5ra02440d ↗
40. 10.1016/j.jcis.2014.07.00510.1016/j.jcis.2014.07.005 ↗
41. Milgrom L. R. · 1997
42. 10.1039/b516042a10.1039/b516042a ↗
43. 10.1186/s11671-018-2514-510.1186/s11671-018-2514-5 ↗
44. Montalti M. · 200610.1201/9781420015195 ↗
45. 10.1039/d2dt01154a10.1039/d2dt01154a ↗
46. 10.1038/srep4134010.1038/srep41340 ↗
47. 10.1002/aoc.659810.1002/aoc.6598 ↗
48. 10.3322/caac.2011410.3322/caac.20114 ↗
49. 10.1038/s41427-021-00303-110.1038/s41427-021-00303-1 ↗